The GOLMePsA study protocol: An investigator-initiated, double-blind, parallelgroup, randomised, controlled trial of GOLimumab and methotrexate versus methotrexate in early diagnosed psoriatic arthritis using clinical and whole body MRI outcomes
7
0
0
13 trang
